Cellebrite DI (NASDAQ:CLBT) PT Increased to $17.00

Cellebrite DI (NASDAQ:CLBT – Get Free Report) Bank of America raised its price target to $17.00 from $13.00 in a research note on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Bank of America’s price target points to a potential upside of 3.41% from the company’s current share price.

Several other equities analysts also weighed in on CLBT. JPMorgan Chase & Co. raised their price target on shares of Cellebrite DI from $14.00 to $15.00 and gave the company an “overweight” rating in a research report on Wednesday. Craig Hallum raised their price target on shares of Cellebrite DI from $16.00 to $20.00 and gave the company a “buy” rating in a report on Friday. Needham & Company LLC raised their price target on Cellebrite DI from $14.00 to $17.00 and gave the stock a “buy” rating in a report on Friday. Finally, Lake Street Capital raised their price target on Cellebrite DI from $13.50 to $17.00 and gave the stock a “buy” rating in a research report on Friday. Seven analysts have rated the stock with a “buy” rating. According to MarketBeat.com, the company currently has a consensus rating of Buy and an average price target of $17.33.

Read our latest stock report on Cellebrite DI

Cellebrite DI Stock Performance

Cellebrite DI shares opened at $16.44 on Friday. The stock has a 50-day simple moving average of $12.66 and a 200-day simple moving average of $11.56. The stock has a market cap of $3.39 billion, a price/earnings ratio of -28.34, a PEG ratio of 1.90 and a beta of 1.50. Cellebrite DI has a 52-week low of $6.36 and a 52-week high of $16.59.

Cellebrite DI (NASDAQ:CLBT – Get Free Report) last released its earnings results on Thursday, August 15. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.08 by $0.02. Cellebrite DI had a positive return on equity of 417.94% and a negative net margin of 32.57%. The company had revenue of $95.70 million during the quarter, compared to the consensus estimate of $91.94 million. During the same period in the prior year, the company reported $0.05 EPS. The company’s revenue for the quarter was up 24.8% from the same quarter last year. Research analysts have predicted that Cellebrite DI will report 0.34 EPS for the current year.

Institutional inflow and outflow

Hedge funds have recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. increased its position in Cellebrite DI by 59.6% in the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company’s stock worth $33,000 after purchasing an additional 1,017 shares in the last quarter. Scalar Gauge Management LLC increased its holdings in Cellebrite DI by 15.2% in the second quarter. Scalar Gauge Management LLC now owns 453,554 shares of the company’s stock worth $5,420,000 after purchasing an additional 60,000 shares in the last quarter. Apis Capital Advisors LLC increased its position in Cellebrite DI shares by 22.3% in the second quarter. Apis Capital Advisors LLC now owns 274,000 shares of the company’s stock worth $3,274,000 after purchasing an additional 50,000 shares during the period. Magnetar Financial LLC purchased a new position in shares of Cellebrite DI in the second quarter worth $143,000. Finally, Sei Investments Co. increased its stake in Cellebrite DI by 16.9% in the second quarter. Sei Investments Co. now owns 141,644 shares of the company’s stock worth $1,693,000 after purchasing an additional 20,478 shares in the last quarter. 45.88% of the shares are held by institutional investors.

Company Profile Cellebrite DI

(Get free report)

Cellebrite DI Ltd. develops solutions for regulatory investigations in Europe, the Middle East, Africa, the Americas and Asia Pacific. The company’s DI solutions enable users to collect, review, analyze and manage digital data throughout the investigation cycle for regulatory investigations used in a variety of cases including child exploitation, homicide, counter-terrorism, border control, sexual crimes, human trafficking, corporate security, cryptocurrency and intellectual property theft.